News Archives | Today's Veterinary Business

Chewy Launches ‘Do Not Crush’ Pet Medication List

The first-of-its-kind, veterinary-specific resource is available as a PDF for veterinary teams or as an online article adapted for pet owners.

The expanded report includes new diagnostic considerations and adds fungal pathogens to help clinical teams combat drug resistance.

The guide outlines distinct metabolic, dental, orthopedic, renal, and cardiovascular risks for canines under 25 pounds.

The Emergency Use Authorization provides veterinarians with a rapid therapeutic option.

The expanded analysis documents major shifts in the home delivery channel.

The non-adjuvanted, low-volume vaccines offer one- and three-year protection options for dogs and cats.

The guidelines encourage a One Health approach and responsible drug use.

The integrated platform provides real-time visibility into a client's pet insurance coverage and financing options at the point of care.

The collaboration gives independent veterinary practices a unified workflow for in-clinic testing and specialty send-out panels.

VETmAb Biosciences' investigational monoclonal antibody has been granted eligibility for the FDA's expanded conditional approval pathway.